- Lasioglossins LLIII affect the morphogenesis of Candida albicans and …
Number of the records: 1  

Lasioglossins LLIII affect the morphogenesis of Candida albicans and reduces the duration of experimental vaginal candidiasis in mice

  1. 1.
    SYSNO ASEP0483187
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleLasioglossins LLIII affect the morphogenesis of Candida albicans and reduces the duration of experimental vaginal candidiasis in mice
    Author(s) Vráblíková, A. (CZ)
    Czerneková, L. (CZ)
    Cahlíková, R. (CZ)
    Nový, Z. (CZ)
    Petřík, M. (CZ)
    Imran, S. (CZ)
    Novák, Z. (US)
    Křupka, M. (CZ)
    Čeřovský, Václav (UOCHB-X) RID, ORCID
    Turánek, J. (CZ)
    Raška, M. (CZ)
    Source TitleMicrobiology and Immunology - ISSN 0385-5600
    Roč. 61, č. 11 (2017), s. 474-481
    Number of pages8 s.
    Languageeng - English
    CountryJP - Japan
    Keywordsantimicrobial peptides ; Candida albicans ; lasioglossins ; vaginal candidiasis
    Subject RIVEE - Microbiology, Virology
    OECD categoryMicrobiology
    R&D ProjectsLO1304 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Institutional supportUOCHB-X - RVO:61388963
    UT WOS000415669400002
    EID SCOPUS85034408174
    DOI https://doi.org/10.1111/1348-0421.12538
    AnnotationLasioglossins are a group of peptides with identified antimicrobial activity. The inhibitory effects of two synthetic lasioglossin derivatives, LLIII and D-isomeric variant LLIII-D, on morphological changes in Candida albicans in vitro and the effect of local administration of LLIII during experimental murine candidiasis were investigated. C. albicans blastoconidia were grown in the presence of lasioglossin LLIII or LLIII-D at concentrations of 11.5M and 21M, respectively, for 1, 2 and 3 days and their viability determined by flow cytometry using eosin Y staining. Morphological changes were examined by light and fluorescent microscopy. The Candida-inhibitory effect of daily intravaginal administration of 0.7 or 1.4g of LLIII was assessed in mice with experimentally-induced vaginal candidiasis. LLIII and LLIII-D lasioglossins exhibited candidacidal activity in vitro (>76% after 24 hr and >84% after 48hr of incubation). After 72hr incubation of Candida with low concentration of lasioglossins, an increase in viability was detected, probably due to a Candida antimicrobial peptides evasion strategy. Furthermore, lasioglossins inhibited temperature-induced morphotype changes toward hyphae and pseudohyphae with sporadic occurrence of atypical cells with two or enlarged nuclei, suggesting interference with mitosis or cytokinesis. Local application of LLIII reduced the duration of experimental candidiasis with no evidence of adverse effects. Lasioglossin LLIII is a promising candidate for development as an antimicrobial drug for treating the vaginal candidiasis.
    WorkplaceInstitute of Organic Chemistry and Biochemistry
    Contactasep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Jana Procházková, Tel.: 220 183 418
    Year of Publishing2018
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.